Sajulga, Kice Nhate C.
HRN: 23-16-72 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/23/2023
06/29/2023
IVTT
600mg
Q8h
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes